Akzo Nobel N.V.
AKZA.AS · AMS
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | €10,363 | €10,157 | €9,681 | €9,900 |
| - Cash | €1,322 | €1,552 | €1,599 | €1,302 |
| + Debt | €5,352 | €5,846 | €5,887 | €5,368 |
| Enterprise Value | €14,393 | €14,451 | €13,969 | €13,966 |
| Revenue | €2,547 | €2,626 | €2,613 | €2,619 |
| % Growth | -3% | 0.5% | -0.2% | – |
| Gross Profit | €1,027 | €1,038 | €1,048 | €1,026 |
| % Margin | 40.3% | 39.5% | 40.1% | 39.2% |
| EBITDA | €34 | €339 | €293 | €225 |
| % Margin | 1.3% | 12.9% | 11.2% | 8.6% |
| Net Income | -€194 | €124 | €107 | €21 |
| % Margin | -7.6% | 4.7% | 4.1% | 0.8% |
| EPS Diluted | -1.13 | 0.72 | 0.62 | 0.12 |
| % Growth | -256.9% | 16.1% | 416.7% | – |
| Operating Cash Flow | €331 | €234 | -€112 | €398 |
| Capital Expenditures | -€55 | -€72 | -€71 | -€114 |
| Free Cash Flow | €276 | €162 | -€183 | €284 |